Angiotensin-converting enzyme and neutral endopeptidase modulate smokeless tobacco-induced increase in macromolecular efflux from the oral mucosa in vivo

Journal of Laboratory and Clinical Medicine

Volumn 130, Issue 4, 1997, Pages 395-400

  Gao, Xiao Pei ^a   Suzuki, Hideyuki ^a   Olopade, Christopher O ^a   Pakhlevaniants, Sergei ^a   Rubinstein, Israel ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0031257648     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(97)90039-1     Document Type: Article

References (29)

1. Connolly GN, Winn DM, Hecht SS, Henningfield JE, Hoffman D, Walker B Jr. The reemergence of smokeless tobacco. N Engl J Med 1986;314:1020-7.
2. Benowitz NL, Jacob P III, Yu L. Daily use of smokeless tobacco: systemic effects. Ann Intern Med 1989;111:112-6.
3. Centers for Disease Control. Tobacco use among high school students-United States, 1990. MMWR 1991;40:617-9.
4. Grady D, Greene J, Ernster VL, Robertson PB, Hauck W, Greenspan D, et al. Oral mucosal lesions found in smokeless tobacco users. J Am Dent Assoc 1990;121:117-23.
5. Shklar G, Niukian K, Hassan M, Herbosa EG. Effects of smokeless tobacco and snuff on oral mucosa of experimental animals. J Oral Maxillofac Surg 1985;43:80-6.
6. Gao X-p, Vishwanatha JK, Conlon JM, Olopade CO, Rubinstein I. Mechanisms of smokeless tobacco-induced buccal mucosa inflammation. Role of bradykinin. J Immunol 1996; 157:4624-33.
7. Bhoola KD, Figueroa CD, Worthy K. Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol Rev 1992;44:1-80.
8. Yong T, Gao X-P, Koizumi S, Conlon JM, Rennard SI, Mayhan WG, et al. Role of peptidases in bradykinin-induced increase in vascular permeability in vivo. Circ Res 1992;70:952-9.
9. Ehlers MR, Riordan JF. Angiotensin-converting enzyme: new concepts concerning its biological role. Biochemistry 1989;28:5311-8.
10. Erdös EG, Skidgel RA. Neutral endopeptidase 24.11 (enkephalinase) and related regulators of peptide hormones. FASEB J 1989;3:145-51.
11. Oh JS, Cherrick HM, Park NH. Effect of snuff extract on the replication and synthesis of vital DNA and proteins in cells infected with herpes simplex virus. J Oral Maxillofac Surg 1990;48:373-9.
12. Müns G, Vishwanatha JK, Rubinstein I. Effects of smokeless tobacco on chemically transformed hamster oral keratinocytes: role of angiotensin I-converting enzyme. Carcinogenesis 1994;15:1325-7.
13. Suzuki H, Gao X-P, Olopade CO, Jaffe HA, Pakhlevaniants S, Rubinstein I. Aqueous smokeless tobacco extract impairs endothelium-dependent vasodilation in the oral mucosa. J Appl Physiol 1996;81:225-31.
14. Gao X-p, Anding P, Robbins RA, Rennard SI, Rubinstein I. Peptidases modulate bradykinin-induced arteriolar dilatation in the hamster cheek pouch. Am J Physiol 1994;266:H93-8.
15. Gao X-p, Rubinstein I. Neutral endopeptidase modulates substance P-induced vasodilation in vivo. J Appl Physiol 1995;72:562-8.
16. Suzuki H, Gao X-P, Olopade CO, Rubinstein I. Neutral endopeptidase modulates VIP-induced vasodilation in hamster cheek pouch vessels in situ. Am J Physiol 1996;271: R393-7.
17. Mayhan WG, Joyner WL. The effect of altering the external calcium concentration and a calcium channel blocker, verapamil, on microvascular leaky sites and dextran clearance in the hamster cheek pouch. Microvasc Res 1984;28:159-79.
18. Myers TO, Joyner WL, Gilmore JP. Extravasation of macromolecules and vascular reactivity of microvessels in response to nicotine in the hamster. Int J Microcirc Clin Exp 1988;7: 139-53.
19. Rubinstein I, Houmsse M, Davis RG, Vishwanatha JK. Tissue angiotensin I-converting enzyme activity in spontaneously hypertensive hamsters. Biochem Biophys Res Commun 1992;183:1117-23.
20. Ashrafi SH, Das A, Worowongvasu R, Mehdinejad B, Waterhouse JP. A light, transmission and scanning electron microscope study of snuff-treated hamster cheek pouch epithelium. Scanning Microscopy 1992;6:183-94.
21. Murray MA, Heistad DD, Mayhan WG. Role of protein kinase C in bradykinin-induced increase in microvascular permeability. Circ Res 1991;68:1340-8.
22. Tomeo AC, Durán WN. Resistance and exchange microvessels are modulated by different PAF receptors. Am J Physiol 1991;261:H1648-52.
23. Ohtani R, Ohashi Y, Muranaga K, Itoh N, Okamoto H. Changes in activity of the renin-angiotensin system of the rat by induction of acute inflammation. Life Sci 1989;44:237-41.
24. Hwang L, Leichter R, Okamoto A, Payan D, Collins SM, Bunnett NW. Downregulation of neutral endopeptidase (EC 3.4.24.11) in the inflamed rat intestine. Am J Physiol 1993; 264:G735-43.
25. Tobacco and the clinician: interventions for medical and dental practice. Bethesda, MD: National Institutes of Health, 1994. Monograph 5. NIH publication 94-3693.
26. Tomar SL, Husten CG, Manley MW. Do dentists and physicians advise tobacco users to quit? J Am Dent Assoc 1996; 127:259-65.
27. Preventing tobacco use among young people. A report of the surgeon general. Atlanta, GA: Centers for Disease Control and Prevention, Office on Smoking and Health:1994.
28. Eakin E, Severson H, Glasgow RE. Development and evaluation of a smokeless tobacco cessation program: a pilot study. In: Smokeless tobacco use in the United States. Monograph 8:95-100. Bethesda, MD: Department of Health and Human Services, National Cancer Institute, 1989.
29. Glover ED. Conducting smokeless tobacco cessation clinics [letter]. Am J Public Health 1986;76;207.